Dosage form: tablet, film coated
Drug classes:Aromatase inhibitors, Hormones / antineoplastics
Medically reviewed by Drugs.com. Last updated on May 1, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
INDICATIONS AND USAGE
Adjuvant Treatment of Postmenopausal Women
Exemestane Tablets are indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to Exemestane Tablets for completion of a total of five consecutive years of adjuvant hormonal therapy [see Clinical Studies (14.1)].
Advanced Breast Cancer in Postmenopausal Women
Exemestane Tablets are indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy [see Clinical Studies (14.2)].
